Bioxytran (BIXT) Change in Inventory (2010 - 2018)
Bioxytran (BIXT) posted Change in Inventory of -$127.0 for Q2 2018, down 108.72% sequentially from $1457.0 in Q1 2018, and up 29.44% YoY from -$98.11 in Q2 2017.
Bioxytran (BIXT) Change in Inventory (2010 - 2018) Analysis & Trends
Bioxytran has reported Change in Inventory for 8 years, with the latest figure at -$127.0 in Q2 2018.
- Quarterly Change in Inventory rose 29.44% year-over-year to -$127.0 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $942.0 (up 106.24% YoY) and the FY2017 annual result came in at -$1008.0, down 116.07% from the prior year.
- Change in Inventory fell to -$127.0 in Q2 2018 per BIXT's latest filing, from $1457.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $2630.0 in Q4 2016 and troughed at -$17114.0 in Q4 2014.
- A 4-year average of -$1770.2 and a median of -$160.0 in 2017 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2014 and 2018: Change in Inventory tumbled 3302.39% in 2014, then surged 431.14% in 2018.
- Over 4 years, Change in Inventory stood at -$17114.0 in 2014, then jumped by 115.37% to $2630.0 in 2016, then plunged by 109.43% to -$248.0 in 2017, then jumped by 48.79% to -$127.0 in 2018.
- According to Business Quant data, Change in Inventory over the past three periods registered -$127.0, $1457.0, and -$248.0 for Q2 2018, Q1 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -280,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 12.97 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 135.26 Mn |
| 10 | Bioxytran | 2.47 Mn | 2.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -127.00 |
| Jun 30, 2018 | -127.00 |
| Mar 31, 2018 | 1,457.00 |
| Mar 31, 2018 | 1,457.00 |
| Dec 31, 2017 | -248.00 |
| Dec 31, 2017 | -248.00 |
| Sep 30, 2017 | -140.00 |
| Sep 30, 2017 | -140.00 |
| Jun 30, 2017 | -180.00 |
| Jun 30, 2017 | -180.00 |
| Mar 31, 2017 | -440.00 |
| Mar 31, 2017 | -440.00 |
| Dec 31, 2016 | 2,630.00 |
| Dec 31, 2016 | 2,630.00 |
| Dec 31, 2014 | -17,114.00 |
| Dec 31, 2014 | -17,114.00 |
| Dec 31, 2013 | -503.00 |
| Dec 31, 2013 | -503.00 |
| Sep 30, 2013 | -1,208.00 |
| Sep 30, 2013 | -1,208.00 |